Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Schoepfer AM"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-15 z 15
    Tytuł:
    Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn's Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study.
    Autorzy:
    Frei R; Department of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.
    Fournier N; Institute of Social and Preventive Medicine [IUMSP], Lausanne University Hospital, Lausanne, Switzerland.
    Zeitz J; Department of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.; Center of Gastroenterology, Clinic Hirslanden, Zurich, Switzerland.
    Scharl M; Department of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.
    Morell B; Department of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.
    Greuter T; Department of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.
    Schreiner P; Department of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.
    Misselwitz B; Department of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.
    Safroneeva E; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Schoepfer AM; Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois [CHUV] and University of Lausanne, Lausanne, Switzerland.
    Vavricka SR; Department of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.; Center of Gastroenterology and Hepatology, Zurich, Switzerland.
    Rogler G; Department of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.
    Biedermann L; Department of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.
    Pokaż więcej
    Źródło:
    Journal of Crohn's & colitis [J Crohns Colitis] 2019 Sep 27; Vol. 13 (10), pp. 1292-1301.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Anti-Inflammatory Agents/*therapeutic use
    Crohn Disease/*drug therapy
    Tumor Necrosis Factor-alpha/*antagonists & inhibitors
    Adult ; Anti-Inflammatory Agents/administration & dosage ; Anti-Inflammatory Agents/adverse effects ; Crohn Disease/complications ; Female ; Follow-Up Studies ; Humans ; Intestinal Obstruction/epidemiology ; Intestinal Obstruction/etiology ; Intestinal Obstruction/prevention & control ; Male ; Middle Aged ; Prospective Studies ; Switzerland ; Time Factors ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors, and Disease Course.
    Autorzy:
    Greuter T; Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
    Piller A; Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
    Fournier N; Insitute of Social and Preventive Medicine, University Hospital Lausanne - CHUV, Lausanne, Switzerland.
    Safroneeva E; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Straumann A; Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
    Biedermann L; Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
    Godat S; Division of Gastroenterology and Hepatology, University Hospital Lausanne - CHUV, Lausanne, Switzerland.
    Nydegger A; Division of Pediatrics, University Hospital Lausanne - CHUV, Lausanne, Switzerland.
    Scharl M; Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
    Rogler G; Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
    Vavricka SR; Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
    Schoepfer AM; Division of Gastroenterology and Hepatology, University Hospital Lausanne - CHUV, Lausanne, Switzerland.
    Pokaż więcej
    Corporate Authors:
    Swiss IBD Cohort Study Group
    Źródło:
    Journal of Crohn's & colitis [J Crohns Colitis] 2018 Nov 28; Vol. 12 (12), pp. 1399-1409.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Crohn Disease*/complications
    Crohn Disease*/diagnosis
    Crohn Disease*/epidemiology
    Crohn Disease*/physiopathology
    Intestinal Fistula*/epidemiology
    Intestinal Fistula*/etiology
    Upper Gastrointestinal Tract*/pathology
    Upper Gastrointestinal Tract*/physiopathology
    Adult ; Age Factors ; Disease Progression ; Female ; Humans ; Logistic Models ; Male ; Predictive Value of Tests ; Prevalence ; Proportional Hazards Models ; Risk Assessment ; Risk Factors ; Sex Factors ; Switzerland/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Adults with eosinophilic oesophagitis identify symptoms and quality of life as the most important outcomes.
    Autorzy:
    Safroneeva E; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Balsiger L; Division of Internal Medicine, Kantonsspital Langenthal, Solothurn, Switzerland.
    Hafner D; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Kuehni CE; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Zwahlen M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Trelle S; Institute of Social and Preventive Medicine, Clinical Trials Unit Bern, University of Bern, Bern, Switzerland.
    Godat S; Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
    Biedermann L; Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
    Greuter T; Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.; Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota.
    Vavricka S; Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
    Straumann A; Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
    Schoepfer AM; Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
    Pokaż więcej
    Źródło:
    Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2018 Nov; Vol. 48 (10), pp. 1082-1090.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Surveys and Questionnaires*
    Eosinophilic Esophagitis/*diagnosis
    Eosinophilic Esophagitis/*psychology
    Focus Groups/*methods
    Patient Education as Topic/*methods
    Quality of Life/*psychology
    Adult ; Endoscopy/psychology ; Endoscopy/trends ; Eosinophilic Esophagitis/therapy ; Female ; Humans ; Male ; Middle Aged ; Pamphlets ; Prospective Studies ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Colectomy Rates in Ulcerative Colitis are Low and Decreasing: 10-year Follow-up Data From the Swiss IBD Cohort Study.
    Autorzy:
    Parragi L; Division of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.
    Fournier N; Institute of Social and Preventive Medicine [IUMSP], Lausanne University Hospital, Lausanne, Switzerland.
    Zeitz J; Division of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.
    Scharl M; Division of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.
    Greuter T; Division of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.
    Schreiner P; Division of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.
    Misselwitz B; Division of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.
    Safroneeva E; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Schoepfer AM; Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois [CHUV] and University of Lausanne, Lausanne, Switzerland.
    Vavricka SR; Division of Gastroenterology, Triemli Hospital Zurich, Zurich, Switzerland.
    Rogler G; Division of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.
    Biedermann L; Division of Gastroenterology, University Hospital Zurich [USZ] and University of Zurich, Zurich, Switzerland.
    Pokaż więcej
    Corporate Authors:
    Swiss IBD Cohort Study Group
    Źródło:
    Journal of Crohn's & colitis [J Crohns Colitis] 2018 Jun 28; Vol. 12 (7), pp. 811-818.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Colectomy/*statistics & numerical data
    Colitis, Ulcerative/*surgery
    Adolescent ; Adult ; Age of Onset ; Aged ; Aged, 80 and over ; Child ; Child, Preschool ; Colectomy/trends ; Colitis, Ulcerative/complications ; Colitis, Ulcerative/diagnosis ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Sex Factors ; Switzerland ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Expression Patterns of TNFα, MAdCAM1, and STAT3 in Intestinal and Skin Manifestations of Inflammatory Bowel Disease.
    Autorzy:
    Vavricka SR; Division of Gastroenterology and Hepatology, University Hospital Zurich, Switzerland.; Division of Gastroenterology and Hepatology, Triemli Hospital Zurich, Switzerland.
    Galván JA; Institute of Pathology, University of Bern, Switzerland.
    Dawson H; Institute of Pathology, University of Bern, Switzerland.
    Soltermann A; Department of Pathology, University Hospital Zurich, Switzerland.
    Biedermann L; Division of Gastroenterology and Hepatology, University Hospital Zurich, Switzerland.
    Scharl M; Division of Gastroenterology and Hepatology, University Hospital Zurich, Switzerland.
    Schoepfer AM; Division of Gastroenterology and Hepatology, University Hospital Lausanne-CHUV, Switzerland.
    Rogler G; Division of Gastroenterology and Hepatology, University Hospital Zurich, Switzerland.
    Prinz Vavricka MB; Private Practice for Dermatology, Praxis Dr. Rümmelein AG, Zurich, Switzerland.
    Terracciano L; Department of Pathology, University Hospital Basel, Switzerland.
    Navarini A; Department of Dermatology, University Hospital Zurich, Switzerland.
    Zlobec I; Institute of Pathology, University of Bern, Switzerland.
    Lugli A; Institute of Pathology, University of Bern, Switzerland.
    Greuter T; Division of Gastroenterology and Hepatology, University Hospital Zurich, Switzerland.
    Pokaż więcej
    Źródło:
    Journal of Crohn's & colitis [J Crohns Colitis] 2018 Feb 28; Vol. 12 (3), pp. 347-354.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Colitis, Ulcerative/*metabolism
    Colitis, Ulcerative/*pathology
    Crohn Disease/*metabolism
    Crohn Disease/*pathology
    Immunoglobulins/*metabolism
    Mucoproteins/*metabolism
    STAT3 Transcription Factor/*metabolism
    Tumor Necrosis Factor-alpha/*metabolism
    Adult ; Aged ; Antigens, CD/metabolism ; Antigens, CD20/metabolism ; Antigens, Differentiation, Myelomonocytic/metabolism ; Biopsy ; Case-Control Studies ; Caspase 3/metabolism ; Caspase 9/metabolism ; Cell Adhesion Molecules ; Colitis, Ulcerative/complications ; Crohn Disease/complications ; Erythema Nodosum/etiology ; Erythema Nodosum/metabolism ; Erythema Nodosum/pathology ; Female ; HSP27 Heat-Shock Proteins/metabolism ; HSP70 Heat-Shock Proteins/metabolism ; Humans ; Immunohistochemistry ; Interferon-gamma/metabolism ; Intestinal Mucosa/metabolism ; Intestines/pathology ; Janus Kinases/metabolism ; Male ; Middle Aged ; NF-kappa B/metabolism ; Psoriasis/etiology ; Psoriasis/metabolism ; Psoriasis/pathology ; Pyoderma Gangrenosum/etiology ; Pyoderma Gangrenosum/metabolism ; Pyoderma Gangrenosum/pathology ; Signal Transduction ; Skin/metabolism ; Skin/pathology ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014.
    Autorzy:
    Bähler C; Department of Health Sciences, Helsana Group, P.O. Box 8081, Zürich, Switzerland. .
    Vavricka SR; Department Gastroenterology and Hepatology, Stadtspital Triemli, Birmensdorferstrasse 497, 8063, Zürich, Switzerland.
    Schoepfer AM; Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois/CHUV, Rue du Bugnon 44, 1011, Lausanne, Switzerland.
    Brüngger B; Department of Health Sciences, Helsana Group, P.O. Box 8081, Zürich, Switzerland.
    Reich O; Department of Health Sciences, Helsana Group, P.O. Box 8081, Zürich, Switzerland.
    Pokaż więcej
    Źródło:
    BMC gastroenterology [BMC Gastroenterol] 2017 Dec 02; Vol. 17 (1), pp. 138. Date of Electronic Publication: 2017 Dec 02.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Health Care Costs*
    Patient Acceptance of Health Care*
    Inflammatory Bowel Diseases/*economics
    Inflammatory Bowel Diseases/*epidemiology
    Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Drug Costs ; Female ; Hospitalization/economics ; Humans ; Infant ; Inflammatory Bowel Diseases/mortality ; Inflammatory Bowel Diseases/therapy ; Male ; Middle Aged ; Prevalence ; Retrospective Studies ; Switzerland/epidemiology ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Eosinophilic oesophagitis: relationship of quality of life with clinical, endoscopic and histological activity.
    Autorzy:
    Safroneeva E; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Coslovsky M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Kuehni CE; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Zwahlen M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Haas NA; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Panczak R; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Taft TH; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
    Hirano I; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
    Dellon ES; University of North Carolina School of Medicine, Chapel Hill, NC, USA.
    Gonsalves N; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
    Leung J; Tufts Medical Center, Boston, MA, USA.
    Bussmann C; Viollier AG, Basel, Switzerland.
    Woosley JT; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
    Yan P; Centre Hospitalier Universitaire Vaudois/CHUV, Lausanne, Switzerland.
    Romero Y; Mayo Clinic, Rochester, MN, USA.
    Furuta GT; University of Colorado School of Medicine; Digestive Health Institute, Children's Hospital Colorado, Aurora, CO, USA.
    Gupta SK; Indiana University School of Medicine, Indianapolis, IN, USA.
    Aceves SS; University of California, San Diego, San Diego, CA, USA.
    Chehade M; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
    Straumann A; University Hospital Basel, Basel, Switzerland.; Swiss EoE Research Group, Praxis Römerhof, Olten Switzerland.
    Schoepfer AM; Centre Hospitalier Universitaire Vaudois/CHUV, Lausanne, Switzerland.
    Pokaż więcej
    Corporate Authors:
    International EEsAI Study Group
    Źródło:
    Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2015 Oct; Vol. 42 (8), pp. 1000-10. Date of Electronic Publication: 2015 Aug 14.
    Typ publikacji:
    Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Quality of Life*
    Eosinophilic Esophagitis/*epidemiology
    Eosinophilic Esophagitis/*pathology
    Adult ; Aged ; Endoscopy ; Endoscopy, Digestive System ; Female ; Humans ; Male ; Middle Aged ; Severity of Illness Index ; Surveys and Questionnaires ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's disease.
    Autorzy:
    Safroneeva E; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
    Vavricka SR; Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.; Division of Gastroenterology and Hepatology, Stadtspital Triemli, Zurich, Switzerland.
    Fournier N; Institut Universitaire de Médecine Sociale et Préventive, Centre Hospitalier Universitaire Vaudois et Université de Lausanne, Lausanne, Switzerland.
    Pittet V; Institut Universitaire de Médecine Sociale et Préventive, Centre Hospitalier Universitaire Vaudois et Université de Lausanne, Lausanne, Switzerland.
    Peyrin-Biroulet L; Inserm U954, Department of Hepato-Gastroenterology, University Hospital of Nancy, Lorraine University, Vandoeuvre-lès-Nancy, France.
    Straumann A; Division of Gastroenterology and Hepatology, University Hospital Basel, Basel, Switzerland.
    Rogler G; Division of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland.
    Schoepfer AM; Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois et Université de Lausanne, Lausanne, Switzerland.
    Pokaż więcej
    Corporate Authors:
    Swiss IBD Cohort Study Group
    Źródło:
    Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2015 Oct; Vol. 42 (8), pp. 977-89. Date of Electronic Publication: 2015 Aug 14.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Early Medical Intervention*
    Crohn Disease/*drug therapy
    Crohn Disease/*epidemiology
    Crohn Disease/*surgery
    Digestive System Surgical Procedures/*statistics & numerical data
    Immunologic Factors/*administration & dosage
    Intestines/*drug effects
    Adalimumab/administration & dosage ; Adalimumab/adverse effects ; Adjuvants, Immunologic/therapeutic use ; Adult ; Aged ; Certolizumab Pegol/administration & dosage ; Certolizumab Pegol/adverse effects ; Cohort Studies ; Crohn Disease/pathology ; Female ; Humans ; Immunologic Factors/adverse effects ; Infliximab/administration & dosage ; Infliximab/adverse effects ; Intestines/pathology ; Intestines/surgery ; Male ; Middle Aged ; Switzerland/epidemiology ; Time Factors ; Tumor Necrosis Factor-alpha/antagonists & inhibitors ; Tumor Necrosis Factor-alpha/immunology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients.
    Autorzy:
    Safroneeva E; University of Bern, Bern, Switzerland.
    Vavricka S; University Hospital Zurich, Zurich, Switzerland.; Stadtspital Triemli, Zurich, Switzerland.
    Fournier N; Centre Hospitalier Universitaire Vaudois et Université de Lausanne, Lausanne, Switzerland.
    Seibold F; Tiefenauspital Bern, Bern, Switzerland.; Inselspital/University Hospital Bern, Bern, Switzerland.
    Mottet C; Centre Hospitalier Universitaire Vaudois et Université de Lausanne, Lausanne, Switzerland.; Hôpital de Neuchâtel, Neuchâtel, Switzerland.
    Nydegger A; Centre Hospitalier Universitaire Vaudois et Université de Lausanne, Lausanne, Switzerland.
    Ezri J; Centre Hospitalier Universitaire Vaudois et Université de Lausanne, Lausanne, Switzerland.
    Straumann A; University Hospital of Basel, Basel, Switzerland.; Praxis Römerhof, Olten, Switzerland.
    Rogler G; University Hospital Zurich, Zurich, Switzerland.
    Schoepfer AM; Centre Hospitalier Universitaire Vaudois et Université de Lausanne, Lausanne, Switzerland.
    Pokaż więcej
    Corporate Authors:
    Swiss IBD Cohort Study Group
    Źródło:
    Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2015 Sep; Vol. 42 (5), pp. 540-8. Date of Electronic Publication: 2015 Jul 06.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Disease Progression*
    Colitis, Ulcerative/*physiopathology
    Adolescent ; Adult ; Aged ; Aged, 80 and over ; Calcineurin Inhibitors/therapeutic use ; Cohort Studies ; Colitis, Ulcerative/drug therapy ; Female ; Glucocorticoids/therapeutic use ; Humans ; Logistic Models ; Male ; Middle Aged ; Odds Ratio ; Remission Induction ; Switzerland ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The gap between scientific evidence and clinical practice: 5-aminosalicylates are frequently used for the treatment of Crohn's disease.
    Autorzy:
    Schoepfer AM; Division of Gastroenterology and Hepatology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.
    Bortolotti M
    Pittet V
    Mottet C
    Gonvers JJ
    Reich O
    Fournier N
    Vader JP
    Burnand B
    Michetti P
    Froehlich F
    Pokaż więcej
    Źródło:
    Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2014 Oct; Vol. 40 (8), pp. 930-7. Date of Electronic Publication: 2014 Aug 22.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use
    Crohn Disease/*drug therapy
    Mesalamine/*therapeutic use
    Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anti-Inflammatory Agents, Non-Steroidal/adverse effects ; Child ; Child, Preschool ; Cohort Studies ; Crohn Disease/epidemiology ; Female ; Humans ; Infant ; Male ; Mesalamine/adverse effects ; Middle Aged ; Surveys and Questionnaires ; Switzerland/epidemiology ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Commentary: the proton pump inhibitor test - does it have a role in eosinophilic oesophagitis? Authors' reply.
    Autorzy:
    Moawad FJ; Gastroenterology Service, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, MD, USA. .
    Schoepfer AM
    Pokaż więcej
    Źródło:
    Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2014 Apr; Vol. 39 (8), pp. 897-8.
    Typ publikacji:
    Journal Article; Comment
    MeSH Terms:
    Endoscopy*
    Eosinophilia/*physiopathology
    Eosinophilic Esophagitis/*physiopathology
    Proton Pump Inhibitors/*therapeutic use
    Female ; Humans ; Male
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings.
    Autorzy:
    Moawad FJ; Gastroenterology Service, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, MD, USA.
    Schoepfer AM
    Safroneeva E
    Ally MR
    Chen YJ
    Maydonovitch CL
    Wong RK
    Pokaż więcej
    Źródło:
    Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2014 Mar; Vol. 39 (6), pp. 603-8. Date of Electronic Publication: 2014 Jan 26.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Endoscopy*
    Eosinophilia/*physiopathology
    Eosinophilic Esophagitis/*physiopathology
    Proton Pump Inhibitors/*therapeutic use
    Adult ; Databases, Factual ; Deglutition Disorders/epidemiology ; Deglutition Disorders/etiology ; Eosinophilia/drug therapy ; Eosinophils/pathology ; Female ; Heartburn/epidemiology ; Heartburn/etiology ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months.
    Autorzy:
    Meyrat P; Private Practice for Gastroenterology and Hepatology, Solothurn, Switzerland. />Safroneeva E
    Schoepfer AM
    Pokaż więcej
    Źródło:
    Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2012 Dec; Vol. 36 (11-12), pp. 1084-93. Date of Electronic Publication: 2012 Oct 16.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Gastrointestinal Agents/*therapeutic use
    Irritable Bowel Syndrome/*drug therapy
    Rifamycins/*therapeutic use
    Adult ; Breath Tests/methods ; Clinical Trials as Topic ; Female ; Humans ; Lactulose ; Male ; Middle Aged ; Rifaximin ; Severity of Illness Index ; Treatment Outcome
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Eosinophilic oesophagitis: latest intelligence.
    Autorzy:
    Schoepfer AM; Department of Gastroenterology and Hepatology, CHUV/University of Lausanne, Lausanne, Switzerland. alain.schoepfer@chuv.ch
    Simon D
    Straumann A
    Pokaż więcej
    Źródło:
    Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2011 May; Vol. 41 (5), pp. 630-9. Date of Electronic Publication: 2011 Mar 24.
    Typ publikacji:
    Journal Article; Review
    MeSH Terms:
    Eosinophilic Esophagitis*/diagnosis
    Eosinophilic Esophagitis*/immunology
    Eosinophilic Esophagitis*/therapy
    Humans ; Hypersensitivity/diagnosis ; Hypersensitivity/immunology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients.
    Autorzy:
    Schoepfer AM; Department of Gastroenterology, Inselspital, Bern University Hospital, Bern, Switzerland. alain.schoepfer@insel.ch
    Schaffer T
    Seibold-Schmid B
    Müller S
    Seibold F
    Pokaż więcej
    Źródło:
    Neurogastroenterology and motility [Neurogastroenterol Motil] 2008 Oct; Vol. 20 (10), pp. 1110-8. Date of Electronic Publication: 2008 Aug 06.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
    MeSH Terms:
    Antibodies/*immunology
    Antigens, Bacterial/*immunology
    Flagellin/*immunology
    Irritable Bowel Syndrome/*immunology
    Adolescent ; Adult ; Aged ; Aged, 80 and over ; Animals ; Autoantibodies/immunology ; Feces/chemistry ; Female ; Gastroenteritis/complications ; Gastroenteritis/microbiology ; Humans ; Irritable Bowel Syndrome/etiology ; Irritable Bowel Syndrome/physiopathology ; Leukocyte L1 Antigen Complex/metabolism ; Middle Aged ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-15 z 15

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies